title: Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
authors.affiliation: Department of Neurology, Kaohsiung Medical University Hospital, and Department of Neurology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
authors.forename: A-Ching
authors.initials: AC
authors.lastname: Chao
authors.affiliation: Department of Neurology, MacKay Memorial Hospital, Taipei, Taiwan.
authors.forename: Helen L
authors.initials: HL
authors.lastname: Po
authors.affiliation: Department of Neurology, Taipei Medical University-Shaung Ho Hospital, Taipei, Taiwan.
authors.forename: Lung
authors.initials: L
authors.lastname: Chan
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator